Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Epitopes

View through CrossRef
AbstractT‐ and B‐cell epitopes differ fundamentally in the way they are recognized by the immune system. B‐cell epitopes are recognized as three‐dimensional structures on the surface of native antigens. T‐cell epitopes are parts of internalized and processed antigens that are presented to T lymphocytes in association with molecules of the major histocompatibility complex. Since in a biological system T‐ and B‐cell receptors or antibody molecules face a virtual infinite number of structures, cognate interactions with epitopes are the basis of the primordial intelligence that drives the teleological choices of the immune system. Although theoretically any antigen comprises a myriad of potential epitopes, the immune response will focus only on a few of them by a phenomenon termed immunodominance. Understanding the mechanisms that govern epitope selection is important for epitope prediction and vaccine design.Key conceptsSurface immunoglobulins of B cells and antibodies recognize the B‐cell epitope of an antigen in its native conformation.The main common feature of B‐cell epitopes (BCEs) is accessibility on the surface of the antigen.T‐cell receptors (TCRs) recognize the T‐cell epitopes (TCEs) only after intracellular processing of the antigen, and in association with major histocompatibility complex (MHC) molecules, a concept termed MHC restriction.TCEs presented by MHC class II molecules are longer and more variable in size than those presented by MHC class I molecules.TCE peptides that bind to the same allele of MHC class I molecules share common ‘anchor’ residues that contact the MHC molecule. In MHC class II‐restricted TCEs, the anchor residues are less well defined.High affinity of the TCR–MHC–peptide tripartite interaction as well as coreceptors and other signalling modules are needed for T‐cell activation.Immunodominance refers to the concept that only a small subset of the potential epitopes (TCEs or BCEs) present in a given antigen elicit an immune response.The immunodominance of a TCE depends on its accessibility within the antigen, the specificity of processing enzymes and its affinity to transporter proteins, chaperons, MHC and TCRs.Mimotopes are small molecules that mimic the structure of complex conformational epitopes without any sequence homology.
Title: Epitopes
Description:
AbstractT‐ and B‐cell epitopes differ fundamentally in the way they are recognized by the immune system.
B‐cell epitopes are recognized as three‐dimensional structures on the surface of native antigens.
T‐cell epitopes are parts of internalized and processed antigens that are presented to T lymphocytes in association with molecules of the major histocompatibility complex.
Since in a biological system T‐ and B‐cell receptors or antibody molecules face a virtual infinite number of structures, cognate interactions with epitopes are the basis of the primordial intelligence that drives the teleological choices of the immune system.
Although theoretically any antigen comprises a myriad of potential epitopes, the immune response will focus only on a few of them by a phenomenon termed immunodominance.
Understanding the mechanisms that govern epitope selection is important for epitope prediction and vaccine design.
Key conceptsSurface immunoglobulins of B cells and antibodies recognize the B‐cell epitope of an antigen in its native conformation.
The main common feature of B‐cell epitopes (BCEs) is accessibility on the surface of the antigen.
T‐cell receptors (TCRs) recognize the T‐cell epitopes (TCEs) only after intracellular processing of the antigen, and in association with major histocompatibility complex (MHC) molecules, a concept termed MHC restriction.
TCEs presented by MHC class II molecules are longer and more variable in size than those presented by MHC class I molecules.
TCE peptides that bind to the same allele of MHC class I molecules share common ‘anchor’ residues that contact the MHC molecule.
In MHC class II‐restricted TCEs, the anchor residues are less well defined.
High affinity of the TCR–MHC–peptide tripartite interaction as well as coreceptors and other signalling modules are needed for T‐cell activation.
Immunodominance refers to the concept that only a small subset of the potential epitopes (TCEs or BCEs) present in a given antigen elicit an immune response.
The immunodominance of a TCE depends on its accessibility within the antigen, the specificity of processing enzymes and its affinity to transporter proteins, chaperons, MHC and TCRs.
Mimotopes are small molecules that mimic the structure of complex conformational epitopes without any sequence homology.

Related Results

Bioinformatic identification of Endemic Coronaviruses’ epitopes in SARS-CoV-2 genomes isolated in Kenya
Bioinformatic identification of Endemic Coronaviruses’ epitopes in SARS-CoV-2 genomes isolated in Kenya
Abstract Identification of SARS-CoV-2 genome regions with similarity to epitopes for endemic coronaviruses is crucial for understanding cross-immunity and designing broad-s...
Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus
Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus
Infectious laryngotracheitis virus (ILTV) is a gallid herpesvirus type 1, a member of the genus Iltovirus. It causes an infection in the upper respiratory tract mainly trachea whic...
Abundance of human T-cell epitopes in microbial proteomes
Abundance of human T-cell epitopes in microbial proteomes
Abstract Molecular mimicry, the structural similarity between self and foreign antigens, is considered as a key factor in post-infectious autoimm...
Structural modeling and conserved epitopes prediction against SARS-COV-2 structural proteins for vaccine development
Structural modeling and conserved epitopes prediction against SARS-COV-2 structural proteins for vaccine development
Abstract Background: Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Corona virus 2 (SARS-COV-2) was first diagnosed in December 2019, Wuhan...
Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2
Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2
Abstract Background In order to obtain antibodies that recognize natural proteins, it is possible to predict the antigenic determinants of natural proteins, which are event...
Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2
Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2
Abstract BackgroundIn order to obtain antibodies that recognize natural proteins, it is possible to predict the antigenic determinants of natural proteins, which are eventu...
Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses
Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses
All types of papillomaviruses (PV) share common, so-called group-specific epitopes. To identify the major group-specific epitopes, we immunized 26 guinea pigs or rabbits with purif...

Back to Top